Streetbeat News

HUGE

FSD Pharma Inc.

https://www.fsdpharma.com

Industry

Drug Manufacturers - Specialty & Generic

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.

Open

0.10

Mkt cap

67K

Volume

22M

High

0.10

P/E Ratio

-0.01

52-wk high

109.19

Low

0.09

Div yield

N/A

52-wk low

0.09

Trading for the stock symbol HUGE was halted at 7:50:00 p.m. ET due to pending news. Investors are advised to stay alert for further updates.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:50 pm

Roger Stone, a longtime ally of former President Donald Trump, believes that Trump's endorsement of a Florida marijuana legalization initiative would guarantee its victory. Trump has yet to take a definitive stance but has indicated he will make a statement soon. The initiative, Amendment 3, has mixed support and opposition, with significant financial backing on both sides. The measure would allow adults 21 and older to purchase and possess cannabis, potentially generating significant tax revenue for the state.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 3:43 pm

Rumble Inc. (NASDAQ:RUM) shares rose 7.1% in pre-market trading after reporting better-than-expected Q2 financial results. Other notable pre-market movers include Vicinity Motor Corp. (NASDAQ:VEV) up 136.7%, MKDWELL Tech Inc. (NASDAQ:MKDW) up 54.1%, and Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) down 56.4%.

Portfolio Pulse from Avi Kapoor

August 13, 2024 | 10:35 am

FSD Pharma Inc. (NASDAQ:HUGE) is rebranding to Quantum BioPharma Ltd. and undergoing a share consolidation to meet Nasdaq's listing requirements. The consolidation will convert every 65 pre-consolidation shares into 1 post-consolidation share, effective August 15, 2024. The company will also conduct a private placement to strengthen voting rights.

Portfolio Pulse from Juan Spínelli

August 12, 2024 | 4:44 pm

Ainos, Inc. (NASDAQ:AIMD) shares surged 37.7% in pre-market trading after securing exclusive licenses for 10 patents from Taiwan Carbon Nano Technology. Other notable pre-market movers include LogicMark, Inc. (NASDAQ:LGMK) up 49% following a $4.5 million public offering, and Meta Materials Inc. (NASDAQ:MMAT) down 27.7% after filing for Chapter 7 bankruptcy.

Portfolio Pulse from Avi Kapoor

August 12, 2024 | 10:04 am

FSD Pharma shares are trading higher following the announcement by Celly Nutrition, a company backed by FSD Pharma, about the upcoming launch of its 'unbuzzd' recovery drink.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 5:25 pm

FSD Pharma Inc. (NASDAQ:HUGE) shares are experiencing significant gains following an update on its investment in Celly Nutrition. The company announced the upcoming launch of its product, unbuzzd, on Amazon and the closing of its first round of financing. Trading volume for FSD Pharma shares has surged, with over 900 million shares traded compared to a float of 40.157 million shares.

Portfolio Pulse from Erica Kollmann

August 09, 2024 | 5:23 pm

US stocks edged lower with the Dow Jones, NASDAQ, and S&P 500 all falling slightly. EchoStar Corporation shares tumbled 16% after reporting worse-than-expected Q2 results. FSD Pharma, Iteris, and Hyzon Motors saw significant gains, while AN2 Therapeutics, Vicinity Motor, and Meta Materials experienced substantial declines.

Portfolio Pulse from Avi Kapoor

August 09, 2024 | 4:29 pm

Doximity, Inc. (NYSE:DOCS) shares surged over 28% in pre-market trading after reporting better-than-expected Q1 financial results and issuing strong FY24 revenue guidance. Other notable pre-market movers include Iteris, Inc. (NASDAQ:ITI) up 61.7% due to an acquisition, and American Vanguard Corporation (NYSE:AVD) down 30.8% after disappointing Q2 results.

Portfolio Pulse from Avi Kapoor

August 09, 2024 | 9:04 am

Carvana Co. (NYSE:CVNA) shares surged 13.4% in pre-market trading after reporting better-than-expected Q2 financial results. Other notable pre-market movers include FSD Pharma Inc. (NASDAQ:HUGE), Immuneering Corporation (NASDAQ:IMRX), and CareDx, Inc (NASDAQ:CDNA) among gainers, while ALX Oncology Holdings Inc. (NASDAQ:ALXO) and Teladoc Health, Inc. (NYSE:TDOC) were among the losers.

Portfolio Pulse from Avi Kapoor

August 01, 2024 | 12:32 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.